TCI Wealth Advisors’s NanoViricides NNVC Stock Holding History

TCI Wealth Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10	Closed	–	–	1424
2016 Q3	$0	Hold	10	–	–	﹤0.01%	1388
2016 Q2	$0	Hold	10	–	–	﹤0.01%	1354
2016 Q1	$0	Hold	10	–	–	﹤0.01%	1383
2015 Q4	$0	Hold	10	–	–	﹤0.01%	1066
2015 Q3	$0	Hold	10	–	–	﹤0.01%	1000
2015 Q2	$0	Hold	10	–	–	﹤0.01%	990
2015 Q1	$0	Buy	+10	New	+$533	﹤0.01%	931

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

TCI Wealth Advisors's NNVC Position: Q4 2016 in Review

TCI Wealth Advisors sold out of NanoViricides (NNVC) in Q4 2016, closing a stake of 10 shares.

TCI Wealth Advisors first reported a position in NNVC in Q1 2015 and held it in 7 quarters. The position peaked at $0 in Q3 2016. 44 funds tracked by Wall St. Rank hold NNVC as of Q4 2016.

TCI Wealth Advisors reported no remaining NanoViricides position as of Q4 2016 after selling out during the quarter.
TCI Wealth Advisors sold 10 NanoViricides shares in Q4 2016.
TCI Wealth Advisors first reported a position in NanoViricides in Q1 2015 and held it in 7 quarters.
TCI Wealth Advisors's NanoViricides position peaked at $0 in Q3 2016.
44 funds tracked by Wall St. Rank held NanoViricides as of Q4 2016.

Based on TCI Wealth Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.